-
公开(公告)号：US20100218315A1
公开(公告)日：2010-09-02
申请号：US12800188
申请日：2010-05-11
申请人： Roderick A. Hyde , Muriel Y. Ishikawa , Edward K.Y. Jung , Eric C. Leuthardt , Royce A. Levien , Robert W. Lord , Mark A. Malamud , Nathan P. Myhrvold , Dennis J. Rivet , John D. Rinaldo, JR. , Michael A. Smith , Clarence T. Tegreene , Lowell L. Wood, JR. , Victoria Y.H. Wood
发明人： Roderick A. Hyde , Muriel Y. Ishikawa , Edward K.Y. Jung , Eric C. Leuthardt , Royce A. Levien , Robert W. Lord , Mark A. Malamud , Nathan P. Myhrvold , Dennis J. Rivet , John D. Rinaldo, JR. , Michael A. Smith , Clarence T. Tegreene , Lowell L. Wood, JR. , Victoria Y.H. Wood
CPC分类号： A61F5/05 , A61G5/1043 , A61G7/05707 , A61G7/0573 , A61G13/12 , A61G2203/34
摘要： One aspect relates to reducing a pressure differential across one or more supporting surfaces of a body surface of an individual at least partially by displacing at least one displaceable contouring unit to at least partially conform to one or more contours of the body surface of the individual. Certain aspects can relate to stabilizing at least the one or more supporting surfaces of the body surface of the individual at least partially with at least one of the at least one displaceable contouring unit Other aspects can relate to relatively displacing at least one displaceable contouring unit with respect to a medical device portion based at least in part on a contour of an individual to support at least a portion of the individual while limiting pressure applied to the individual.
摘要翻译： 一个方面涉及通过使至少一个可移位的轮廓单元至少部分地符合个体的身体表面的一个或多个轮廓来至少部分地减小穿过个体的身体表面的一个或多个支撑表面的压差。 至少部分地至少部分地使至少一个可移位的轮廓单元稳定至少一个或多个支撑表面的某些方面可以涉及至少一个可移动轮廓加工单元中的至少一个。其它方面可以涉及相对移位至少一个可移位的轮廓单元， 至少部分地基于个体的轮廓来相对于医疗装置部分，以支持个体的至少一部分，同时限制施加到个体的压力。
-
公开(公告)号：US20100169259A1
公开(公告)日：2010-07-01
申请号：US12387151
申请日：2009-04-28
申请人： Roderick A. Hyde , Robert Langer , Eric C. Leuthardt , Robert W. Lord , Elizabeth A. Sweeney , Clarence T. Tegreene , Lowell L. Wood, JR.
发明人： Roderick A. Hyde , Robert Langer , Eric C. Leuthardt , Robert W. Lord , Elizabeth A. Sweeney , Clarence T. Tegreene , Lowell L. Wood, JR.
IPC分类号： G06N5/02
CPC分类号： A61B5/0484 , A61B5/01 , A61B5/02 , A61B5/024 , A61B5/11 , A61B5/145 , A61B5/14532 , A61B5/165 , A61B5/411 , A61B5/4833 , A61B5/4839 , A61B5/486 , A61B5/6822 , A61M11/00 , A61M15/00 , A61M15/0028 , A61M15/0065 , A61M15/009 , A61M15/02 , A61M15/08 , A61M2021/0016 , A61M2205/3553 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/588 , A61M2209/088 , A61M2230/201 , A61M2230/205 , A63F2300/65 , A63F2300/6692 , G06F19/3462
摘要： Methods, computer program products, and systems are described that include accepting an indication of an individual's compliance with an artificial sensory experience and presenting an indication of an inhalation device-dispensed bioactive agent at least partially based on the indication of the individual's compliance with the artificial sensory experience.
摘要翻译： 描述了方法，计算机程序产品和系统，其包括接受个人对人造感觉经验的遵守的指示，并且至少部分地基于个体对人造物的符合性的指示来呈现吸入装置分配的生物活性剂的指示 感官体验。
-
103.发明申请公开(公告)号：US20100163576A1
公开(公告)日：2010-07-01
申请号：US12590049
申请日：2009-10-30
申请人： Edward S. Boyden , Daniel B. Cook , Roderick A. Hyde , Eric C. Leuthardt , Nathan P. Myhrvold , Elizabeth A. Sweeney , Lowell L. Wood, JR.
发明人： Edward S. Boyden , Daniel B. Cook , Roderick A. Hyde , Eric C. Leuthardt , Nathan P. Myhrvold , Elizabeth A. Sweeney , Lowell L. Wood, JR.
CPC分类号： G06F19/00 , A61K9/0019 , A61K9/0021 , A61K9/007 , A61K9/08 , A61K9/1611 , A61K9/1617 , A61K9/1641 , A61K9/1664 , A61K9/1688 , A61K9/19 , A61K31/00 , A61K31/337 , A61K31/70 , A61K31/7008 , A61K31/7088 , A61K33/00 , A61K38/38 , A61K38/4833 , A61K38/4886 , A61K39/00 , A61K41/0004 , A61K45/06 , A61K51/1244 , B33Y80/00 , A61K2300/00
摘要： Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one substrate.
摘要翻译： 本文公开的某些实施方案涉及关于冷冻颗粒的组合物，方法，装置，系统和产品。 在某些实施方案中，冷冻颗粒包括低温下的材料。 在某些实施方案中，冷冻颗粒提供用于递送特定试剂的载体。 在某些实施方案中，将冷冻颗粒施用于至少一种底物。
-
公开(公告)号：US20100163038A1
公开(公告)日：2010-07-01
申请号：US12387321
申请日：2009-04-30
申请人： Roderick A. Hyde , Robert Langer , Eric C. Leuthardt , Robert W. Lord , Elizabeth A. Sweeney , Clarence T. Tegreene , Lowell L. Wood, JR.
发明人： Roderick A. Hyde , Robert Langer , Eric C. Leuthardt , Robert W. Lord , Elizabeth A. Sweeney , Clarence T. Tegreene , Lowell L. Wood, JR.
IPC分类号： A61M16/10
CPC分类号： A61B5/0484 , A61B5/01 , A61B5/02 , A61B5/024 , A61B5/11 , A61B5/145 , A61B5/14532 , A61B5/165 , A61B5/411 , A61B5/4833 , A61B5/4839 , A61B5/486 , A61B5/6822 , A61M11/00 , A61M15/00 , A61M15/0028 , A61M15/0065 , A61M15/009 , A61M15/02 , A61M15/08 , A61M2021/0016 , A61M2205/3553 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/588 , A61M2209/088 , A61M2230/201 , A61M2230/205 , A63F2300/65 , A63F2300/6692 , G06F19/3462
摘要： Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of an inhalation device-dispensed bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the inhalation device-dispensed bioactive agent to the individual.
-
公开(公告)号：US20100163026A1
公开(公告)日：2010-07-01
申请号：US12378485
申请日：2009-02-13
申请人： Roderick A. Hyde , Robert Langer , Eric C. Leuthardt , Robert W. Lord , Elizabeth A. Sweeney , Clarence T. Tegreene , Lowell L. Wood, JR.
发明人： Roderick A. Hyde , Robert Langer , Eric C. Leuthardt , Robert W. Lord , Elizabeth A. Sweeney , Clarence T. Tegreene , Lowell L. Wood, JR.
IPC分类号： A61M16/10
CPC分类号： A61B5/0484 , A61B5/01 , A61B5/02 , A61B5/024 , A61B5/11 , A61B5/145 , A61B5/14532 , A61B5/165 , A61B5/411 , A61B5/4833 , A61B5/4839 , A61B5/486 , A61B5/6822 , A61M11/00 , A61M15/00 , A61M15/0028 , A61M15/0065 , A61M15/009 , A61M15/02 , A61M15/08 , A61M2021/0016 , A61M2205/3553 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/588 , A61M2209/088 , A61M2230/201 , A61M2230/205 , A63F2300/65 , A63F2300/6692 , G06F19/00 , G06F19/3462
摘要： Methods, computer program products, and systems are described that include accepting an indication of at least one health-related condition and presenting an indication of at least one artificial sensory experience and an indication of at least one inhalation therapy at least partially based on the accepting at least one indication of a health-related condition.
摘要翻译： 描述了方法，计算机程序产品和系统，其包括接受至少一个健康相关状况的指示，并且至少部分地基于接受的方式呈现至少一种人造感觉体验和至少一种吸入治疗的指示 至少有一个与健康有关的状况的指示。
-
公开(公告)号：US20100141052A1
公开(公告)日：2010-06-10
申请号：US12462796
申请日：2009-08-07
申请人： Roderick A. Hyde , Muriel Y. Ishikawa , Eric C. Leuthardt , Michael A. Smith , Lowell L. Wood, JR. , Victoria Y.H. Wood
发明人： Roderick A. Hyde , Muriel Y. Ishikawa , Eric C. Leuthardt , Michael A. Smith , Lowell L. Wood, JR. , Victoria Y.H. Wood
摘要： A system for utilizing power extracted from intraluminal pressure changes may comprise: (a) an intraluminal generator; (b) an intraluminal pressure change-receiving structure operably coupled to the intraluminal generator; and (c) a power utilization device.A system for utilizing power extracted from intraluminal pressure changes may comprise: (a) means for receiving an intraluminal pressure change; (b) means for converting an intraluminal pressure change into energy with an intraluminal generator; and (c) means for providing the energy to a power utilization device.
摘要翻译： 用于利用从腔内压力变化提取的功率的系统可以包括：（a）管腔内发生器; （b）可操作地连接到腔内发生器的腔内压力变化 - 接收结构; 和（c）电力利用装置。 用于利用从腔内压力变化提取的功率的系统可以包括：（a）用于接收管腔内压力变化的装置; （b）用管腔内发生器将腔内压力变化转换为能量的装置; 和（c）用于向能量利用装置提供能量的装置。
-
公开(公告)号：US20100137844A1
公开(公告)日：2010-06-03
申请号：US12315510
申请日：2008-12-02
IPC分类号： A61K9/22
CPC分类号： A61K31/497 , A61K9/0019 , A61K9/19 , A61K9/2018 , A61K31/00 , A61K31/145 , A61K31/4725 , A61K31/506 , A61K45/06 , A61M5/14276 , A61M5/16827 , A61M5/1723 , A61M2205/0244 , A61M2205/50 , A61M2205/52 , G06F19/3468 , Y02A50/411 , Y02A90/26 , A61K2300/00
摘要： Certain embodiments disclosed relate to compositions, including therapeutic compositions, methods, devices, and systems that modulate at least one inflammatory response or reaction. According to various embodiments, the compositions, methods, devices, and systems relate to modulating one or more of Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes.
摘要翻译： 所公开的某些实施方案涉及调节至少一种炎性反应或反应的组合物，包括治疗组合物，方法，装置和系统。 根据各种实施方案，组合物，方法，装置和系统涉及调节Toll样受体，Src家族激酶，NF-kB分子，蛋白酶或蛋白酶体中的一种或多种。
-
公开(公告)号：US20100137787A1
公开(公告)日：2010-06-03
申请号：US12315512
申请日：2008-12-02
CPC分类号： A61K31/497 , A61K9/0019 , A61K9/19 , A61K9/2018 , A61K31/00 , A61K31/145 , A61K31/4725 , A61K31/506 , A61K45/06 , A61M5/14276 , A61M5/16827 , A61M5/1723 , A61M2205/0244 , A61M2205/50 , A61M2205/52 , G06F19/3468 , Y02A50/411 , Y02A90/26 , A61K2300/00
摘要： Certain embodiments disclosed relate to compositions, including therapeutic compositions, methods, devices, and systems that modulate at least one inflammatory response or reaction. According to various embodiments, the compositions, methods, devices, and systems relate to modulating one or more of Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes.
-
公开(公告)号：US20100136096A1
公开(公告)日：2010-06-03
申请号：US12315513
申请日：2008-12-02
IPC分类号： A61K9/127 , A61K31/439 , A61K31/506 , A61K31/4706 , A61K31/145 , A61K31/69 , A61K31/7088 , A61K38/02 , A61K31/739 , A61K31/70
CPC分类号： A61K31/145 , A61K9/0019 , A61K9/19 , A61K9/20 , A61K9/4825 , A61K31/439 , A61K31/4706 , A61K31/506 , A61K31/69 , A61K31/70 , A61K31/7088 , A61K31/739 , A61K38/02 , A61K45/06 , Y02A50/411 , A61K2300/00
摘要： Certain embodiments disclosed relate to compositions, including therapeutic compositions, methods, devices, and systems that modulate at least one inflammatory response or reaction. According to various embodiments, the compositions, methods, devices, and systems relate to modulating one or more of Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes.
摘要翻译： 所公开的某些实施方案涉及调节至少一种炎性反应或反应的组合物，包括治疗组合物，方法，装置和系统。 根据各种实施方案，组合物，方法，装置和系统涉及调节Toll样受体，Src家族激酶，NF-kB分子，蛋白酶或蛋白酶体中的一种或多种。
-
公开(公告)号：US20100131875A1
公开(公告)日：2010-05-27
申请号：US12462128
申请日：2009-07-28
申请人： Shawn P. Firminger , Jason Garms , Edward K.Y. Jung , Chris D. Karkanias , Eric C. Leuthardt , Royce A. Levien , Robert W. Lord , Mark A. Malamud , John D. Rinaldo, JR. , Clarence T. Tegreene , Kristin M. Tolle , Lowell L. Wood, JR.
发明人： Shawn P. Firminger , Jason Garms , Edward K.Y. Jung , Chris D. Karkanias , Eric C. Leuthardt , Royce A. Levien , Robert W. Lord , Mark A. Malamud , John D. Rinaldo, JR. , Clarence T. Tegreene , Kristin M. Tolle , Lowell L. Wood, JR.
CPC分类号： G06N5/02
摘要： A computationally implemented method includes, but is not limited to: presenting to a user a hypothesis identifying at least a relationship between a first event type and a second event type; receiving from the user one or more modifications to modify the hypothesis; and executing one or more actions based, at least in part, on a modified hypothesis resulting, at least in part, from the reception of the one or more modifications. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
-
-
-
-
-
-
-
-
-
搜索结果
1666 条记录 (耗时 0.071 秒)
